Aprogen Biologics (003060) Price & Analysis

― Followers

003060 Stock Chart & Stats

$2090.00

$5.00(0.24%)

Jul 27, 2026

―

Day’s Range― - ―

52-Week Range$1,869.00 - $10,395.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)N/A

Market Cap

₩28.31B

Enterprise ValueN/A

Total Cash (Recent Filing)₩50.10B

Total Debt (Recent Filing)₩227.15B

Price to Earnings (P/E)―

Beta0.18

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-9942.55

Shares Outstanding14,412,374

10 Day Avg. VolumeN/A

30 Day Avg. VolumeN/A

Financial Highlights & Ratios

PEG Ratio>-0.01

Price to Book (P/B)0.50

Price to Sales (P/S)1.41

P/FCF Ratio-2.15

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

003060 FAQ

What was Aprogen Biologics’s price range in the past 12 months?

Aprogen Biologics lowest stock price was $1869.00 and its highest was $10395.00 in the past 12 months.

What is Aprogen Biologics’s market cap?

Aprogen Biologics’s market cap is ₩28.31B.

When is Aprogen Biologics’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Aprogen Biologics’s earnings last quarter?

Aprogen Biologics released its earnings results on May 14, 2026. The company reported -$295.479 earnings per share for the quarter, missing the consensus estimate of N/A by -$295.479.

Is Aprogen Biologics overvalued?

According to Wall Street analysts Aprogen Biologics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Aprogen Biologics pay dividends?

Aprogen Biologics does not currently pay dividends.

What is Aprogen Biologics’s EPS estimate?

Aprogen Biologics’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Aprogen Biologics have?

Aprogen Biologics has 14,412,374 shares outstanding.

What happened to Aprogen Biologics’s price movement after its last earnings report?

Aprogen Biologics reported an EPS of -$295.479 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.082%.

Which hedge fund is a major shareholder of Aprogen Biologics?

Currently, no hedge funds are holding shares in KR:003060

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Aprogen Biologics

Aprogen Biologics, Inc. specializes in the production and distribution of pharmaceutical goods. The company's activities are structured across two main segments: Pharmaceutical and Bio. Its Pharmaceutical division supplies synthetic medicines, encompassing treatments for the circulatory, central nervous, and digestive systems, alongside antibiotics. Concurrently, the Bio division is dedicated to developing and manufacturing biopharmaceuticals. Aprogen Biologics was established on December 3, 1960, and its corporate headquarters are situated in Seoul, South Korea.